S. PNUEMONIAE TRANSCYTOSIS PROTEIN

摘要

The present invention relates to a vaccine formulation providing protection against infection of a subject by a meningeal pathogen, said formulation comprising an effective amount of the protein MgtA or an immunogenic part thereof together with at least one of a pharmaceutically acceptable diluent, carrier, excipient or adjuvant therefore.